• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

半乳糖凝集素-3的核转运及其治疗意义。

Nuclear transport of galectin-3 and its therapeutic implications.

作者信息

Funasaka Tatsuyoshi, Raz Avraham, Nangia-Makker Pratima

机构信息

Nanzando Pharmacies Co., Takanawa, Minato-ku, Tokyo 108-0074, Japan.

Department of Oncology, School of Medicine, Wayne State University, United States.

出版信息

Semin Cancer Biol. 2014 Aug;27:30-8. doi: 10.1016/j.semcancer.2014.03.004. Epub 2014 Mar 19.

DOI:10.1016/j.semcancer.2014.03.004
PMID:24657939
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4108496/
Abstract

Galectin-3, a member of β-galactoside-binding gene family is a multi-functional protein, which regulates pleiotropic biological functions such as cell growth, cell adhesion, cell-cell interactions, apoptosis, angiogenesis and mRNA processing. Its unique structure enables it to interact with a plethora of ligands in a carbohydrate dependent or independent manner. Galectin-3 is mainly a cytosolic protein, but can easily traverse the intracellular and plasma membranes to translocate into the nucleus, mitochondria or get externalized. Depending on the cell type, specific experimental conditions in vitro, cancer type and stage, galectin-3 has been reported to be exclusively cytoplasmic, predominantly nuclear or distributed between the two compartments. In this review we have summarized the dynamics of galectin-3 shuttling between the nucleus and the cytoplasm, the nuclear transport mechanisms of galectin-3, how its specific interactions with the members of β-catenin signaling pathways affect tumor progression, and its implications as a therapeutic target.

摘要

半乳糖凝集素-3是β-半乳糖苷结合基因家族的成员,是一种多功能蛋白质,可调节多种生物学功能,如细胞生长、细胞黏附、细胞间相互作用、细胞凋亡、血管生成和mRNA加工。其独特的结构使其能够以依赖或不依赖碳水化合物的方式与大量配体相互作用。半乳糖凝集素-3主要是一种胞质蛋白,但可以很容易地穿过细胞内和质膜,转移到细胞核、线粒体或外化。根据细胞类型、体外特定实验条件、癌症类型和阶段,据报道半乳糖凝集素-3仅存在于细胞质中、主要存在于细胞核中或分布于这两个区室之间。在这篇综述中,我们总结了半乳糖凝集素-3在细胞核和细胞质之间穿梭的动态过程、半乳糖凝集素-3的核转运机制、其与β-连环蛋白信号通路成员的特异性相互作用如何影响肿瘤进展,以及其作为治疗靶点的意义。

相似文献

1
Nuclear transport of galectin-3 and its therapeutic implications.半乳糖凝集素-3的核转运及其治疗意义。
Semin Cancer Biol. 2014 Aug;27:30-8. doi: 10.1016/j.semcancer.2014.03.004. Epub 2014 Mar 19.
2
Nucleoporin Nup98 mediates galectin-3 nuclear-cytoplasmic trafficking.核孔蛋白 Nup98 介导半乳糖凝集素-3 的核质转运。
Biochem Biophys Res Commun. 2013 Apr 26;434(1):155-61. doi: 10.1016/j.bbrc.2013.03.052. Epub 2013 Mar 26.
3
Galectin-3 in angiogenesis and metastasis.半乳糖凝集素-3在血管生成与转移中的作用
Glycobiology. 2014 Oct;24(10):886-91. doi: 10.1093/glycob/cwu086. Epub 2014 Aug 18.
4
Non-classical role of Galectin-3 in cancer progression: translocation to nucleus by carbohydrate-recognition independent manner.Galectin-3 在癌症进展中的非经典作用:通过碳水化合物识别独立的方式转移到细胞核中。
BMB Rep. 2020 Apr;53(4):173-180. doi: 10.5483/BMBRep.2020.53.4.020.
5
Dynamics of galectin-3 in the nucleus and cytoplasm.半乳糖凝集素-3在细胞核与细胞质中的动态变化。
Biochim Biophys Acta. 2010 Feb;1800(2):181-9. doi: 10.1016/j.bbagen.2009.07.005. Epub 2009 Jul 16.
6
Nucleocytoplasmic shuttling of galectin-3.半乳糖凝集素-3的核质穿梭
Methods Mol Biol. 2015;1207:465-83. doi: 10.1007/978-1-4939-1396-1_30.
7
Galectin-3 as a multifunctional protein.半乳糖凝集素-3作为一种多功能蛋白质。
Cell Mol Biol Lett. 2004;9(2):305-28.
8
Characterization of the nuclear import pathways of galectin-3.半乳糖凝集素-3核输入途径的特征
Cancer Res. 2006 Oct 15;66(20):9995-10006. doi: 10.1158/0008-5472.CAN-06-1772.
9
Regulation of cancer-related gene expression by galectin-3 and the molecular mechanism of its nuclear import pathway.半乳糖凝集素-3对癌症相关基因表达的调控及其核输入途径的分子机制
Cancer Metastasis Rev. 2007 Dec;26(3-4):605-10. doi: 10.1007/s10555-007-9095-6.
10
Galectin-3 and cancer stemness.半乳糖凝集素-3 与癌症干性。
Glycobiology. 2018 Apr 1;28(4):172-181. doi: 10.1093/glycob/cwy001.

引用本文的文献

1
Galectin-3: Integrator of Signaling via Hexosamine Flux.半乳糖凝集素-3:通过己糖胺通量的信号整合因子。
Biomolecules. 2025 Jul 16;15(7):1028. doi: 10.3390/biom15071028.
2
Galectin-3 in Cardiovascular Health: A Narrative Review Based on Life's Essential 8 and Life's Simple 7 Frameworks.半乳糖凝集素-3与心血管健康:基于生命基本八项和生命简单七项框架的叙述性综述
Curr Issues Mol Biol. 2025 May 6;47(5):332. doi: 10.3390/cimb47050332.
3
Galectin-3 Release in the Bone Marrow Microenvironment Promotes Drug Resistance and Relapse in Acute Myeloid Leukemia.

本文引用的文献

1
Why anti-Bcl-2 clinical trials fail: a solution.抗Bcl-2临床试验为何失败:一种解决方案。
Cancer Metastasis Rev. 2014 Mar;33(1):285-94. doi: 10.1007/s10555-013-9450-8.
2
Galectin-3 silencing inhibits epirubicin-induced ATP binding cassette transporters and activates the mitochondrial apoptosis pathway via β-catenin/GSK-3β modulation in colorectal carcinoma.沉默半乳糖凝集素-3 通过β-连环蛋白/GSK-3β 调节抑制表阿霉素诱导的 ABC 转运蛋白并激活结直肠癌细胞中的线粒体凋亡途径。
PLoS One. 2013 Nov 26;8(11):e82478. doi: 10.1371/journal.pone.0082478. eCollection 2013.
3
Nucleoporin Nup98 mediates galectin-3 nuclear-cytoplasmic trafficking.
骨髓微环境中半乳糖凝集素-3的释放促进急性髓系白血病的耐药性和复发。
Life (Basel). 2025 Jun 10;15(6):937. doi: 10.3390/life15060937.
4
Multifaceted roles of Galectins: from carbohydrate binding to targeted cancer therapy.半乳糖凝集素的多方面作用:从碳水化合物结合到靶向癌症治疗。
Biomark Res. 2025 Mar 25;13(1):49. doi: 10.1186/s40364-025-00759-1.
5
HDAC7 drives glioblastoma to a mesenchymal-like state via LGALS3-mediated crosstalk between cancer cells and macrophages.组蛋白去乙酰化酶7通过半乳糖凝集素3介导的癌细胞与巨噬细胞之间的串扰,将胶质母细胞瘤驱动至间充质样状态。
Theranostics. 2024 Oct 21;14(18):7072-7087. doi: 10.7150/thno.100939. eCollection 2024.
6
Galectin-3 induces pathogenic immunosuppressive macrophages through interaction with TREM2 in lung cancer.半乳糖凝集素-3 通过与肺癌中的 TREM2 相互作用诱导致病性免疫抑制性巨噬细胞。
J Exp Clin Cancer Res. 2024 Aug 13;43(1):224. doi: 10.1186/s13046-024-03124-6.
7
Scrutinising the Conformational Ensemble of the Intrinsically Mixed-Folded Protein Galectin-3.深入研究天然混合折叠蛋白半乳糖凝集素-3的构象集合。
Molecules. 2024 Jun 11;29(12):2768. doi: 10.3390/molecules29122768.
8
Galectin-3's Complex Interactions in Pancreatic Ductal Adenocarcinoma: From Cellular Signaling to Therapeutic Potential.半乳糖凝集素-3 在胰腺导管腺癌中的复杂相互作用:从细胞信号到治疗潜力。
Biomolecules. 2023 Oct 10;13(10):1500. doi: 10.3390/biom13101500.
9
Knockdown of BAP31 Downregulates Galectin-3 to Inhibit the Wnt/β-Catenin Signaling Pathway to Modulate 5-FU Chemosensitivity and Cancer Stemness in Colorectal Cancer.敲低BAP31可下调半乳糖凝集素-3以抑制Wnt/β-连环蛋白信号通路,从而调节结直肠癌中5-氟尿嘧啶的化疗敏感性和癌症干性。
Int J Mol Sci. 2023 Sep 21;24(18):14402. doi: 10.3390/ijms241814402.
10
Targeting intracellular galectins for cancer treatment.靶向细胞内半乳糖凝集素治疗癌症。
Front Immunol. 2023 Sep 11;14:1269391. doi: 10.3389/fimmu.2023.1269391. eCollection 2023.
核孔蛋白 Nup98 介导半乳糖凝集素-3 的核质转运。
Biochem Biophys Res Commun. 2013 Apr 26;434(1):155-61. doi: 10.1016/j.bbrc.2013.03.052. Epub 2013 Mar 26.
4
Molecular aspects of cancer cell resistance to chemotherapy.癌细胞对化疗耐药性的分子机制。
Biochem Pharmacol. 2013 May 1;85(9):1219-26. doi: 10.1016/j.bcp.2013.02.017. Epub 2013 Feb 19.
5
Regulation of autophagy by nucleoporin Tpr.核孔蛋白 Tpr 对自噬的调控
Sci Rep. 2012;2:878. doi: 10.1038/srep00878. Epub 2012 Nov 20.
6
The inactive form of glycogen synthase kinase-3β is associated with the development of carcinomas in galectin-3 wild-type mice, but not in galectin-3-deficient mice.糖原合酶激酶-3β的无活性形式与半乳糖凝集素-3野生型小鼠的癌发生有关,但在半乳糖凝集素-3缺陷型小鼠中则不然。
Int J Clin Exp Pathol. 2012;5(6):547-54. Epub 2012 Jul 17.
7
Nuclear pore dynamics during the cell cycle.核孔在细胞周期中的动态变化。
Curr Opin Cell Biol. 2012 Aug;24(4):453-9. doi: 10.1016/j.ceb.2012.06.004. Epub 2012 Jul 5.
8
The sweet and bitter sides of galectins in melanoma progression.半乳糖凝集素在黑色素瘤进展中的甜与苦两面。
Pigment Cell Melanoma Res. 2012 Sep;25(5):592-601. doi: 10.1111/j.1755-148X.2012.01026.x. Epub 2012 Jul 12.
9
The transport of integral membrane proteins across the nuclear pore complex.整膜蛋白穿过核孔复合体的运输。
Nucleus. 2012 Jul 1;3(4):322-9. doi: 10.4161/nucl.20439. Epub 2012 May 22.
10
A change in nuclear pore complex composition regulates cell differentiation.核孔复合体组成的改变调节细胞分化。
Dev Cell. 2012 Feb 14;22(2):446-58. doi: 10.1016/j.devcel.2011.11.021. Epub 2012 Jan 19.